|
HS Code |
675881 |
| Chemical Name | Ginsenoside Rd |
| Molecular Formula | C48H82O18 |
| Molecular Weight | 947.15 g/mol |
| Cas Number | 52705-93-8 |
| Appearance | White to off-white powder |
| Solubility | Soluble in DMSO, slightly soluble in water |
| Purity | ≥98% (HPLC) |
| Storage Temperature | 2-8°C (refrigerated) |
| Source | Extracted from Panax ginseng |
| Usage | Research on neuroprotection and anti-inflammatory activities |
As an accredited Ginsenoside Rd factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ginsenoside Rd is packaged in a clear, sealed glass vial containing 10 mg of fine, off-white powder, labeled with product details. |
| Shipping | Ginsenoside Rd is shipped in secure, airtight containers to prevent contamination and degradation. The package is clearly labeled, accompanied by a Safety Data Sheet (SDS). It is typically transported under cool, dry conditions, with temperature control if required, and complies with relevant regulations for chemical and pharmaceutical materials. |
| Storage | Ginsenoside Rd should be stored in a cool, dry, and well-ventilated place, ideally at -20°C, protected from light and moisture. The container must be tightly sealed to prevent degradation and contamination. Avoid exposure to heat and strong oxidizing agents. Proper labeling and secure storage help ensure chemical stability and safe handling. |
Competitive Ginsenoside Rd prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Years spent in the trenches perfecting plant extraction pay off in every batch of Ginsenoside Rd. With a purity topping 98% by HPLC, we don’t cut corners or water things down. Our model GRd-98 keeps specifications tight, with moisture below 2% and ash capped at 1.5%. The product comes as a fine off-white powder, drawing a line between bulk saponin blends and precision isolates. We stick to proven Panax ginseng roots as our starting material, brought in only from experienced, reliable sources. Sourcing plays a bigger role than most think; wild foraged or low-grade roots don’t offer the same consistency or yield.
Ginsenoside Rd separates itself early in production, right at extraction. Many factories batch-extract crude saponins, pool them, then try to fractionate single actives. We run counter-current chromatography that picks out the Rd fraction before impurities spiral upward. This method keeps byproducts down and stops quality drift between lots. The risk with shortcuts pops up in residual solvent levels — a real concern for buyers focused on safety. Every lot registers at non-detectable limits for ethanol or methanol when measured down to 0.001%. Regulatory trends in Asia and Europe point to even stricter controls, so this matters in the long run.
Within the mix of natural saponins, Rd carries its own muscle. It draws research interest for neuroprotective, anti-inflammatory, and moderate immunoregulatory roles—not just standard adaptogenic support. Unlike Rg1 or Rb1, Rd gets picked up in later fractions; it resists breakdown when other ginsenosides hydrolyze away. This gives Rd a more stable shelf life, an edge in supply chains where transit times last weeks, and an overall less bitter taste in formulation. Some cosmetic chemists prefer Rd for serums and creams because it doesn’t yellow as quickly as others under daylight or room temperatures.
Customers span nutraceutical, cosmetic, and some clinical research fields. Nutraceutical blends use 2% to 10% by weight, based on finished dose needs; capsule and powder drink mixes work best given powder’s easy dispersibility. Our powder’s mesh size, about 80, prevents caking and lets end-users blend without dust plumes or settling particles. Cosmetic developers add between 0.5% and 1% to concentrate masks, serums, and ampoule formulations. We learned the hard way: stirring at low speed for longer periods yields a smoother finished batch than cranking agitation up, especially at higher concentrations.
Researchers tend to request custom smaller batches—sometimes dissolved in DMSO or ethanol—and ask for full stability profiles. We pulled extra stability tests after noticing particle changes following sea transit in summer. Products held their structure even after two months at 35°C/60%RH, something not every saponin isolate can claim. Fielding all these custom requests strengthens process control and transparency.
Early days showed us how small slips can throw an entire production schedule. Sourcing inconsistent root lots or skipping overnight drying would cause batch failures or put stability at risk. Using precision fermentation steps instead of open-air hydrolysis sharply reduced the levels of side-products and helped with compliance testing abroad. Rejecting borderline lots, even with raw plant material in short supply, keeps trust high. Feedback came in from one regular buyer who flagged a single jar with caking after humid storage. We adjusted packaging, reinforcing double-seals and switching desiccant bags, and have not had repeat issues since.
On-site QA teams run every batch through TLC fingerprinting and HPLC purity tests against in-house standards. We publish third-party COAs on request, but our records show fewer deviations now than five years ago. This comes from standardizing every step, right down to the screening of cleaning agents on contact surfaces. Occasional open audits from visiting certifying bodies never feel comfortable, but every inspection so far has returned us with higher marks and practical improvement notes.
Most traders and new market entrants bulk-order unspecified ginsenoside mixes or standard 20%-40% saponin powders. These prove cheaper upfront but lead to unpredictable blends, higher lots-to-lot taste drift, and erratic functionalities. We focus on single-molecule isolation for Rd, sacrificing higher yield for precise, targeted bioactivities. Customers working with cognitive formulations note that Rd’s specificity softens formulation complexity and reduces off-target effects in their tests compared to broader-acting Rb1 or Rc.
Some suppliers push “enriched extract” blends under Ginsenoside Rd’s banner. These don’t guarantee purity or dosing, meaning formulations can fall short of label claims. Our experience preparing documentation for clinical trial partners revealed the struggle generic blends pose: without consistent purity, getting ethics or regulatory approval moves from hard to impossible. This puts pure, validated Rd—not “ginsenoside complex”—at the front of compliance for quality-minded partners.
Cleaning up the process matters to us. Solvent recycling cuts waste, but only tight protocols keep cross-contamination at bay. We invest in charcoal filtration and multi-stage condensers that pull solvents from exhaust before they reach air or water outlets. Spent Panax material gets composted into local fertilizer blends, satisfying local agriculture partnerships. In wet season, managing water runoff and careful effluent testing become priorities—regulators keep a close watch, and so do we.
Selecting only roots grown to maturity supports farmland longevity. Overharvesting, common with wild foraged ginseng, strips soils and undermines crop cycles. Working with growers who rotate plots, keep to controlled densities, and replant, we stabilize supply chains and sidestep the boom-bust cycle that marks other regions. The more we invest upfront in these partnerships, the more even and reliable the quality remains.
Ginsenoside Rd ships airtight, in triple-layered PET containers with tamper evidence. We seal all batches in-house within a Class 100 cleanroom, skipping third-party packaging vendors who can introduce contamination. Bulk customers prefer 500g to 1kg plastic drums, with a nitrogen flush at pack-off to prevent oxidation during shipment, especially to marine-transit-heavy regions. For high-value buyers, each drum receives a unique trace number tied back to our lot database, supporting recalls or compliance tracking if any issue arises downstream.
Warm, wet climates proved problematic for some partners—so we piloted climate-chilled logistics in cooperation with freight partners in Southeast Asia. Failures in the supply line—like a missed cold chain during monsoon season—taught us to include time-temperature recorders and shock indicators for any container crossing certain routes. Direct feedback from formulation customers revealed that maintaining these controls saved finished product shelf-lives and averted several loss claims.
Long-term relationships with external labs and research partners put fresh demands on consistency and responsiveness. We participate in several university-led projects exploring Ginsenoside Rd’s pharmacodynamics and pharmacokinetics. These partners require COAs, batch chromatograms, and supply chain traceability down to input lot numbers. Providing this level of data didn’t happen instantly; it took years of digitizing records and building a reference archive. Now, supplying this support makes us a preferred supplier in published research—an honor that brings new insights and tough questions back that feed our next round of process improvements.
Recent regulatory updates in both North America and Asia threw a few curveballs at extract manufacturers this year, especially around solvent residues, heavy metals, and ginsenoside labeling. We follow CODEX and USP best practices, sharing full materials traceability with buyers. Ginsenoside Rd’s single-molecule status aligns with the standards set by leading Pharmacopeias, whereas crude mixes have sparked warnings in import inspections. Labeling transparency heads off customs delays and reassures end-user clients. Our technical staff tracks upcoming changes and revises testing or labeling with plenty of lead time for downstream partners, avoiding shipment holds or legal snags.
Our daily business reinforces one core lesson: there are no shortcuts in high-purity plant extract manufacturing. Equipment upgrades pay for themselves when a new filter, pump, or sensor uncovers a subtle but recurring defect. Early in our journey, customer returns and internal QC holds cost far more than planned, stressing the need for robust process documentation. Incremental improvements—like switching silica gel vendors or extending drying cycles—have yielded consistent gains over flashier one-shot investments. We guard against complacency by running blind audits and challenge tests every quarter; feedback drives new rounds of R&D and tweaks to operational procedures.
Supply chain interruptions hit everyone in this sector, especially when global shipping lags or seasonal storms disrupt harvests. Keeping a buffer stock of root material—stored under climate control separate from production lines—became our safeguard. Standardizing communication with long-term growers and backup suppliers paid off in crisis years. It rarely feels pleasant to overcommit in the short run, but partners relying on uninterrupted supply appreciate this discipline.
The real-world performance of Ginsenoside Rd comes out in client applications, not just in a lab notebook. We draw technical support from direct conversations with formulation pharmacists, beverage developers, or personal care chemists launching new products. Most development cycles ask for guidance on dosing, solubility tweaks, or color stability. Our technical team shares in-use trials and troubleshooting, supplying empirical advice for water-dispersible forms or suggestions for carrier agents if sticking issues develop in mixing tanks. Every report of clumping, slurry settling, or flavor impact gets added to our troubleshooting knowledge base.
From formulation bench to consumer packaging, product stability rides on decisions made far upstream. Where competitors risk drift batch-to-batch, we focus on tools—like inline NIR spectroscopy for blend uniformity, or real-time digital logging—that catch problems before they cascade into costly recalls. Often, the root causes of field complaints trace all the way back to missed points in plant selection, poorly maintained extraction columns, or lack of sealed storage on-site. We keep open lines for technical support after delivery—seeing every customer complaint as a learning opportunity, not a sunk cost.
The demand for high-character purity in plant actives is growing. More partners seek out single-molecule ginsenosides for investigational and functional food uses. Some are leveraging Ginsenoside Rd in slow-release capsules, transdermal patches, or as a lead compound in targeted pharmaceutical development. As new delivery technologies come to market, our R&D focus tracks along—testing particle size control, improving dissolution kinetics, and exploring new, lower-impact solvents for greener production. Ongoing work with sequence-guided enzyme hydrolysis could yield even sharper purities in the future.
Data-backed traceability and direct field-to-factory connections remain key for the next era of extract manufacturing. Every lesson learned and feedback gathered shapes new protocols, strengthens partnerships, and pushes standards higher across the sector. We commit to raising the bar for ourselves and for the customers who build better, clearer, safer products from the best Ginsenoside Rd available.
